SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-19-007566
Filing Date
2019-10-10
Accepted
2019-10-10 18:58:54
Documents
2
Period of Report
2019-08-26

Document Format Files

Seq Description Document Type Size
1 birndorf-form3_101019.html 3  
1 birndorf-form3_101019.xml 3 2852
2 POWER OF ATTORNEY ex24.htm EX-24 8558
  Complete submission text file 0001387131-19-007566.txt   12896
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NANOGEN INC 10398 PACIFIC CENTER COURT SAN DIEGO CA 92121
Business Address
BIRNDORF HOWARD C (Reporting) CIK: 0001078432 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36242 | Film No.: 191146840